Skip navigation

Align Global Data Collection and Analysis Systems • Ensure Cross Functional Collaboration and Preparedness • Achieve Accurate and Timely Reporting

November 7-8, 2018
  • Washington, DC

Being adequately prepared for pharmacovigilance audits and inspections is crucial to any bio/pharma company committed to maintaining the highest standards for safety and risk management.

CBI’s Pharmacovigilance Audits and Inspections Summit provides insights on the most pressing issues and challenges related to managing the growing volume and frequency of audits and inspections.

It examines complex issues such as managing large scale data sets tied to your PVMF, facilitating cross departmental PV engagement, developing detailed audit plans, generating timely and insightful reports, and tracking evolving global regulations.

Organizations that want to reach a continual state of PV audit readiness can’t afford to miss this chance to benchmark and learn from both colleagues and vendors that have successfully navigated these pathways.

Top Reasons to Attend:

  • Participate in interactive “How To” sessions on how to improve your audit and inspection management processes
  • Examine forthcoming global and domestic regulatory changes
  • “Ted Talk” style discussions featuring experienced pharmacovigilance specialists sharing real life lessons learned on inspections and best practices
  • Navigate the murky waters of data management to optimize reporting, monitoring and validation methods
  • Gather tactics on ways to manage signal detection and signal management
  • Explore and benchmark with peers on ways to develop stronger automation programs

Pharmacovigilance Audits and Inspections Summit

Align Global Data Collection and Analysis Systems • Ensure Cross Functional Collaboration and Preparedness • Achieve Accurate and Timely Reporting

Being adequately prepared for pharmacovigilance audits and inspections is crucial to any bio/pharma company committed to maintaining the highest standards for safety and risk management.

CBI’s Pharmacovigilance Audits and Inspections Summit provides insights on the most pressing issues and challenges related to managing the growing volume and frequency of audits and inspections.

It examines complex issues such as managing large scale data sets tied to your PVMF, facilitating cross departmental PV engagement, developing detailed audit plans, generating timely and insightful reports, and tracking evolving global regulations.

Organizations that want to reach a continual state of PV audit readiness can’t afford to miss this chance to benchmark and learn from both colleagues and vendors that have successfully navigated these pathways.

Top Reasons to Attend:

  • Participate in interactive “How To” sessions on how to improve your audit and inspection management processes
  • Examine forthcoming global and domestic regulatory changes
  • “Ted Talk” style discussions featuring experienced pharmacovigilance specialists sharing real life lessons learned on inspections and best practices
  • Navigate the murky waters of data management to optimize reporting, monitoring and validation methods
  • Gather tactics on ways to manage signal detection and signal management
  • Explore and benchmark with peers on ways to develop stronger automation programs